Literature DB >> 26834070

Repeatability of selective laser trabeculoplasty.

Julia Polat1, Lindsay Grantham2, Kenneth Mitchell3, Tony Realini3.   

Abstract

PURPOSE: To determine the intraocular pressure (IOP)-lowering efficacy of repeat 360° selective laser trabeculoplasty (SLT) in patients with open-angle glaucoma having undergone prior successful 360° SLT.
METHODS: A retrospective chart review of 38 eyes of 38 patients with open-angle glaucoma (primary, pseudoexfoliation or pigmentary glaucoma) uncontrolled on medical therapy who had undergone two successive 360° SLT treatments, in whom first SLT was deemed clinically successful through a minimum of 6 months follow-up and who were followed for a minimum of 30 days after second SLT. Mean IOP at each postoperative time point (1, 3, 6, 12, 18 and 24 months) was compared with baseline using paired t tests. IOP changes after initial and repeat SLT were evaluated separately.
RESULTS: Mean (SD) baseline IOP before initial SLT was 21.6 (4.8) mm Hg. Mean IOP following initial SLT was significantly below baseline through 24 months of follow-up, with mean IOP at months 1-24 ranging from 15.9 to 18.6 mm Hg. Mean baseline IOP before repeat SLT was 19.1 (3.9) mm Hg, with a significant reduction in IOP from baseline through 24 months follow-up with mean IOP ranging from 14.7 to 17.0 mm Hg. Kaplan-Meier survival analysis showed longer median survival time for repeat SLT compared with initial SLT. No safety issues were observed with repeat SLT.
CONCLUSIONS: Repeat SLT can restore IOP control in eyes with open-angle glaucoma that have previously undergone successful initial SLT. Repeat SLT achieves comparable absolute level of IOP control achieved by initial SLT. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Glaucoma; Intraocular pressure; Treatment Lasers

Mesh:

Year:  2016        PMID: 26834070     DOI: 10.1136/bjophthalmol-2015-307486

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  16 in total

1.  A cost minimisation analysis comparing iStent accompanying cataract surgery and selective laser trabeculoplasty versus topical glaucoma medications in a public healthcare setting in New Zealand.

Authors:  Kelvin Ngan; Ewan Fraser; Sophie Buller; Alex Buller
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-08-21       Impact factor: 3.117

Review 2.  Selective laser trabeculoplasty: past, present, and future.

Authors:  A Garg; G Gazzard
Journal:  Eye (Lond)       Date:  2018-01-05       Impact factor: 3.775

Review 3.  A Review of Selective Laser Trabeculoplasty: "The Hype Is Real".

Authors:  Tomislav Sarenac; Anela Bečić Turkanović; Peter Ferme; Tomaž Gračner
Journal:  J Clin Med       Date:  2022-07-04       Impact factor: 4.964

4.  Peripheral anterior synechiae after selective laser trabeculoplasty among Chinese patients.

Authors:  Jonathan Cheuk-Hung Chan; Rachel Ka-Ying Cheung; Perseus Wing-Fu Wong; Jimmy Shiu-Ming Lai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-05-07       Impact factor: 3.535

Review 5.  Lasers in Glaucoma: an Overview.

Authors:  Bhawesh Chandra Saha; Rashmi Kumari; Bibhuti Prasanna Sinha; Anita Ambasta; Sanjeev Kumar
Journal:  Int Ophthalmol       Date:  2020-11-19       Impact factor: 2.031

6.  West Indies Glaucoma Laser Study (WIGLS)-2: Predictors of Selective Laser Trabeculoplasty Efficacy in Afro-Caribbeans With Glaucoma.

Authors:  Tony Realini; Hazel Shillingford-Ricketts; Darra Burt; Goundappa K Balasubramani
Journal:  J Glaucoma       Date:  2018-10       Impact factor: 2.503

7.  Recent trends in glaucoma surgery: a nationwide database study in Japan, 2011-2019.

Authors:  Asahi Fujita; Yohei Hashimoto; Hiroki Matsui; Hideo Yasunaga; Makoto Aihara
Journal:  Jpn J Ophthalmol       Date:  2022-01-19       Impact factor: 2.447

8.  Low-energy Selective Laser Trabeculoplasty Repeated Annually: Rationale for the COAST Trial.

Authors:  Tony Realini; Gus Gazzard; Mark Latina; Michael Kass
Journal:  J Glaucoma       Date:  2021-07-01       Impact factor: 2.290

9.  Long-Term Outcomes of Selective Laser Trabeculoplasty for Open-Angle Glaucoma in the Caribbean.

Authors:  Tony Realini; Hazel Shillingford-Ricketts; Darra Burt; Goundappa K Balasubramani
Journal:  Am J Ophthalmol       Date:  2021-06-18       Impact factor: 5.258

Review 10.  The Role of Minimally Invasive Glaucoma Surgery Devices in the Management of Glaucoma.

Authors:  Murray Fingeret; Jaime E Dickerson
Journal:  Optom Vis Sci       Date:  2018-02       Impact factor: 1.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.